A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

Clinical trial NCT03161093 · COMPLETED

Trial details

NCT number: NCT03161093
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Start date: 2017-08-17
Primary completion: 2019-09-09
Enrollment: 3307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.